Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2022-05-01
2022-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Materials and Methods: This study, which is planned as an open-label randomized controlled post-test study, will be carried out between December 2021 and February 2022. Data; Descriptive Properties will be collected with the Information Form and Visual Analog Scale (Visual Analog Scale-VAS). Data will be collected face to face by researchers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Dıfferent Tournıques and Posıtıons on Paın, Anxıety Levels and Applıcatıon Success in Perıpheral Intravenous Catheter Applıcatıon: a Randomızed Controlled Study
NCT06862921
Comparison of Different Methods of Nasogastric Tube Insertion in Anesthetized and Intubated Patients
NCT02557204
Midline Catheter Versus Long Peripheral Intravenous Catheter in Hospitalized Adult Patients
NCT05884294
The Process of Blood Collection With a Vascular Imaging Device
NCT05678504
Prevention of Phlebitis, Infiltration and Extravasation With Infusion Monitoring System
NCT07046624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The effective application of interventions such as transfusion of intravenous fluids, chemotherapy drugs, blood and blood products, and total parenteral feeding in cancer patients is provided by PVK. The application of PVC is a necessity for the treatment of the individual receiving treatment and may cause pain, deterioration in comfort and dissatisfaction. Although the widespread use of peripheral venous catheters provides great benefits, it has been reported that undesirable events such as phlebitis, infiltration, obstruction, leakage, and rarely infection occur when applied incorrectly and inadequately. In order for peripheral venous catheters to be used effectively in treatment, it is important to fix them with the correct technique. Detection becomes more important in the use of chemotherapy agents. The patches used for fixation adhere to the glove and are difficult to remove from the patient's skin. Therefore, both the nurse and the patient feel discomfort. For this reason, it would be appropriate to use a material that can be easily torn off with a glove, does not adhere to the glove, and fixes the patient's catheter well. This product should also be able to be easily removed without harming the patient's skin.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
masking tape group
Masking tape will be used
Masking tape
IV catheters will be fixed with masking tape
standard catheter dressing group
Medical plaster to be used (It is routine practice in the clinic.)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Masking tape
IV catheters will be fixed with masking tape
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being open to communication and cooperation
* Being conscious and able to answer questions
* Volunteering for research
* Being receiving chemotherapy treatment with a peripheral venous catheter
Exclusion Criteria
* Having sensory losses such as vision and hearing
* Being in terminal period
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Necmettin Erbakan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rukiye Burucu
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Necmettin Erbakan Univercity
Konya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
123456
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.